Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

R -- Drug Efficacy Study

Active
Ref1016946Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The FDA plans to negotiate a sole-source contract on a non-competitive basis with Dr. Herbert Gerstenzang to continue his work on updating the Drug Efficacy Study Implementation and the Drug Registration and Listing System. This decision is based on Dr. Gerstenzang’s extensive experience, unique qualifications, and ongoing involvement in scientific and clinical services related to these systems. The contract will span one year, beginning in September 2006, and will be awarded using simplified acquisition procedures without a formal solicitation process. This notification serves only as an intent to negotiate and does not constitute a solicitation. The contract title is "R -- Drug Efficacy Study," and it falls under NAICS code 519190. For further inquiries, the point of contact is Roberta M. Richardson, reachable by phone or email. Specific details such as the office address and place of performance have not been provided.

General Info

FDA intends a sole-source contract with Dr. Gerstenzang for drug efficacy studies, starting September 2006.

Agency

N/A

NAICS

519190 - All Other Information Services

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts

Full Description

Show more
FDA intends to negotiate on a non-competitive basis with Herbert Gerstenzang for services to continue current work being performed on updating the Drug Efficacy Study Implementation and Drug Registration and Listing System. The period of performance is for one year and will begin in Sep 2006. This sole source is based on extensive experience, unique credentials and work being done by Dr.Herbert Gerstenzang in scientific and clinical services updating the Drug Efficacy Study Implementation and Drug Registration and Listing System. There is no written solicitation for this for this requirement. This is a notice of intent and cannot be considered a solicitation package. Award will be made using simplified acquisition procedures.

Similar Contracts

Same NAICS industry code

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS